Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The nose-to-brain pathway has been proven to be a shortcut for direct drug delivery to the brain. However, whether and to what extent nanoparticles can be delivered through this passage is still awaiting validation with evidence. In this study, nose-to-brain transportation of nanoparticles is tracked via fluorescence bioimaging strategies using nanoemulsions (NEs) as model carriers. Identification of NEs in biological tissues is based on the on → off signal switching of a new type of environment-responsive embedded dyes, P2 and P4, and two conventional probes, DiR and coumarin-6 (C6), are embedded to represent the cargoes. Evidence for the translocation of NEs was collected either via live imaging or ex vivo histological examination in rats after nasal administration. Results suggest that NEs with a particle size of about 100 nm, either naked or coated with chitosan, have longer retention duration in nostrils and slower mucociliary clearance than larger ones. P2 signals, representing integral NEs, can be found in mucosa and trigeminal nerves for all size groups, whereas only weak P2 signals are detected in the olfactory bulb for chitosan-coated NEs of 100 nm. Confocal microscopy further confirms the translocation of integral 100 nm NEs in nasal mucosa and along the trigeminal nerve in decremental intensity. Weak signals of the P4 probe, also representing integral NEs, can be detected in the olfactory bulb but few in the brain. NEs as large as 900 nm cannot be transported to the olfactory bulb. However, the DiR or C6 signals that represent the cargoes can be found in significant amounts along the nose-to-brain pathway and finally reach the brain. Evidence shows that integral NEs can be delivered to the olfactory bulb, but few to the brain, whereas the cargoes can be released and permeated into the brain in greater amounts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NEs of about 100 nm have a prolonged residence duration in the nasal cavity, whereas NEs of larger sizes are characterized by faster clearance.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [72]
In the citing paper
“Particle size, rather than surface coating with chitosan or thickening with thermosensitive in situ gel, plays the most important role in determining the in vivo fate of NEs.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [72]
In the citing paper
“Imaging showed that NEs of 100 nm were transported through the trigeminal and the olfactory nerves to the olfactory bulb.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [72]
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides
Drin, G., Cottin, S., Blanc, E., Rees, A. R., & Temsamani, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303938200 · Cited by 530
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Chitosan in nasal delivery systems for therapeutic drugs
Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 444
Zhuang, X., Teng, Y., Samykutty, A., Mu, J., Deng, Z., Zhang, L., Cao, P., Rong, Y., Yan, J., Miller, D., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.188 · Cited by 294
Yang, Z.-Z., Zhang, Y.-Q., Wang, Z.-Z., Wu, K., Lou, J.-N., & Qi, X.-R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.009 · Cited by 248
Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., & Seta, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.036 · Cited by 241
Research works printed but not linked: 1
- Huang, 1996, Int. J. Pharm. Adv., 1, 298
Cited by
Chitosan-Based Nanomaterials for Drug Delivery
Li, J., Cai, C., Li, J., Li, J., Li, J., Sun, T., Wang, L., Wu, H., & Yu, G. (2018) · Molecules · doi:10.3390/molecules23102661 · Cited by 481
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Drug delivery to the central nervous system
Nance, E., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 414
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
“, fluorescent dye) and it is the nanoemulsion droplet diameter that mainly contributes to the nanoemulsion fate post intranasal administration in comparison with the mucoadhesive coating or the gel impregnation [14].”
BackgroundSurface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
“Ahmad [75] studied the permanence of a nanoemulsion made with Labrafac®WL1349/Labrafac®CC (Gattefossé, Saint-Priest, France) and Solutol®HS15 (BASF, Mumbai, India) in the nasal cavity of rats from 0.”
MethodCosta, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 303
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 298
Qi, J., Hu, X., Dong, X., Lu, Y., Lu, H., Zhao, W., & Wu, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.009 · Cited by 292
Self-citationNanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
Mura, P., Maestrelli, F., Cirri, M., & Mennini, N. (2022) · Marine Drugs · doi:10.3390/md20050335 · Cited by 250
Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences
Zhang, A., Meng, K., Liu, Y., Pan, Y., Qu, W., Chen, D., & Xie, S. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102261 · Cited by 246
Wang, Z., Xiong, G., Tsang, W. C., Schätzlein, A. G., & Uchegbu, I. F. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258152 · Cited by 231
Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 216
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 209
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C., Moreira, J. N., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 210
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 184
Nose-to-brain peptide delivery – The potential of nanotechnology
Samaridou, E., & Alonso, M. J. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 178
Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway
Chen, Y., Zhang, C., Huang, Y., Ma, Y., Song, Q., Chen, H., Jiang, G., & Gao, X. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115196 · Cited by 172
Self-citationIntranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 170
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Hong, S.-S., Oh, K. T., Choi, H.-G., & Lim, S.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100540 · Cited by 162
Hua, T., Kiran, S., Li, Y., & Sang, Q. A. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128884 · Cited by 174
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Gandhi, S. J., Shastri, D. H., Shah, J., Nair, A. B., & Jacob, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040481 · Cited by 179
Nguyen, T.-T.-L., & Maeng, H.-J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030572 · Cited by 130
An update on the role of nanovehicles in nose-to-brain drug delivery
Feng, Y., He, H., Li, F., Lü, Y., Qi, J., & Wu, W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.005 · Cited by 135
Self-citationWang, W., Huang, Z., Li, Y., Wang, W., Shi, J., Fu, F., Huang, Y., Pan, X., & Wu, C. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.023 · Cited by 135
Visual validation of the measurement of entrapment efficiency of drug nanocarriers
Lv, Y., He, H., Qi, J., Lü, Y., Zhao, W., Dong, X., & Wu, W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.025 · Cited by 122
Self-citationLiang, H., Chen, A., Lai, X., Liu, J., Wu, J., Kang, Y., Wang, X., & Shao, L. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0274-0 · Cited by 125
Lü, Y., Lv, Y., & Li, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.006 · Cited by 121
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson’s Disease
Liu, J., Liu, C., Zhang, J., Zhang, Y., Liu, K., Song, J., Sreenivasmurthy, S. G., Wang, Z., Shi, Y., Chu, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b06453 · Cited by 120
Su, Y., Sun, B., Gao, X., Dong, X., Fu, L., Zhang, Y., Li, Z., Wang, Y., Jiang, H., & Han, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01165 · Cited by 119
Self-citationMusumeci, T., Serapide, M. F., Pellitteri, R., Dalpiaz, A., Ferraro, L., Magro, R. D., Bonaccorso, A., Carbone, C., Veiga, F., Sancini, G., et al. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.002 · Cited by 118
Recent progress in nanocarriers for direct nose to brain drug delivery
Emad, N. A., Ahmed, B., Alhalmi, A., Alzobaidi, N., & Al-Kubati, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102642 · Cited by 131
Chitosan-Based Nanocarriers for Nose to Brain Delivery
Aderibigbe, B. A., & Naki, T. (2019) · Applied Sciences · doi:10.3390/app9112219 · Cited by 111
Fan, W., Peng, H., Yu, Z., Wang, L., He, H., Ma, Y., Qi, J., Lü, Y., & Wu, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.016 · Cited by 98
Self-citationAhmad, S., Khan, I., Pandit, J., Emad, N. A., Bano, S., Imtiyaz, K., Rizvi, M. M. A., Ansari, M. D., Aqil, M., & Sultana, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.210 · Cited by 103
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery
Alshweiat, A., Ambrus, R., & Csóka, I. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190827151741 · Cited by 90
Adnet, T., Groo, A., Picard, C., Davis, A., Corvaisier, S., Since, M., Bounoure, F., Rochais, C., Pluart, L. L., Dallemagne, P., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030251 · Cited by 88
The biological fate of orally administered mPEG-PDLLA polymeric micelles
He, H., Wang, L., Ma, Y., Yang, Y., Lv, Y., Zhang, Z., Qi, J., Dong, X., Zhao, W., Lu, Y., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.024 · Cited by 82
Self-citationNanomodulation of Macrophages in Multiple Sclerosis
Nally, F. K., Santi, C. D., & McCoy, C. E. (2019) · Cells · doi:10.3390/cells8060543 · Cited by 83
Updates on thermosensitive hydrogel for nasal, ocular and cutaneous delivery
Wang, Q., Zuo, Z., Cheung, C. K. C., & Leung, S. S. Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.030 · Cited by 81
González, L. F., Acuña, E., Arellano, G., Morales, P., Sotomayor, P. C., Oyarzun-Ampuero, F. A., & Naves, R. F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.019 · Cited by 83
Extracellular vesicles for the treatment of central nervous system diseases
Gratpain, V., Mwema, A., Labrak, Y., Muccioli, G. G., Pesch, V. V., & Rieux, A. D. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.006 · Cited by 82
Xie, Y., Shi, B., Xia, F., Qi, J., Dong, X., Zhao, W., Li, T., Wu, W., & Lü, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.046 · Cited by 76
Self-citationQu, Y., Li, A., Ma, L., Iqbal, S., Sun, X., Ma, W., Li, C., Zheng, D., Xu, Z., Zhao, Z., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120250 · Cited by 73
Uppuluri, C. T., Ravi, P. R., & Dalvi, A. V. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120881 · Cited by 82
Nose-to-brain/spinal cord delivery kinetics of liposomes with different surface properties
Kurano, T., Kanazawa, T., Ooba, A., Masuyama, Y., Maruhana, N., Yamada, M., Iioka, S., Ibaraki, H., Kosuge, Y., Kondo, H., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.017 · Cited by 80
Borrajo, M. L., & Alonso, M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01086-2 · Cited by 78
Chung, E. P., Cotter, J. D., Prakapenka, A. V., Cook, R. L., DiPerna, D. M., & Sirianni, R. W. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020093 · Cited by 69
Shen, C., Yang, Y., Shen, B., Xie, Y., Qi, J., Dong, X., Zhao, W., Zhu, W., Wu, W., Yuan, H., et al. (2017) · Nanoscale · doi:10.1039/c7nr06052a · Cited by 69
Self-citationAntimicrobial Essential Oil Formulation: Chitosan Coated Nanoemulsions for Nose to Brain Delivery
Rinaldi, F., Oliva, A., Sabatino, M., Imbriano, A., Hanieh, P. N., Garzoli, S., Mastroianni, C. M., Angelis, M. D., Miele, M. C., Arnaut, M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070678 · Cited by 67
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Saha, P., Kathuria, H., & Pandey, M. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.021 · Cited by 71
Lipid-based nanoparticles via nose-to-brain delivery: a mini review
Xinchen, Y., Jing, T., & Jiaoqiong, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1214450 · Cited by 77
Ferreira, N. N., Granja, S., Boni, F. I., Prezotti, F. G., Ferreira, L. M. B., Cury, B. S. F., Reis, R. M., Baltazar, F., & Gremião, M. P. D. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00824-2 · Cited by 65
He, H., Xie, Y., Lv, Y., Qi, J., Dong, X., Zhao, W., Wu, W., & Lü, Y. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800711 · Cited by 61
Self-citationLv, Y., Wu, W., Corpstein, C. D., Li, T., & Lü, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114466 · Cited by 56
Self-citationNojoki, F., Ebrahimi-Hosseinzadeh, B., Hatamian-Zarmi, A., Khodagholi, F., & Khezri, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113450 · Cited by 61
Agbo, C. P., Ugwuanyi, T. C., Ugwuoke, W. I., McConville, C., Attama, A. A., & Ofokansi, K. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.020 · Cited by 62
Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence
Misra, S. K., & Pathak, K. (2023) · Colloids and Interfaces · doi:10.3390/colloids7010023 · Cited by 60
Overcoming or circumventing the stratum corneum barrier for efficient transcutaneous immunization
Chen, Z., Lv, Y., Qi, J., Zhu, Q., Lü, Y., & Wu, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.017 · Cited by 53
Self-citationLipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Nguyen, T. T., Nguyen, T. T. D., An, T. N. M., & Giau, V. V. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03488-7 · Cited by 55
Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions
Fan, W., Yu, Z., Peng, H., He, H., Lü, Y., Qi, J., Dong, X., Zhao, W., & Wu, W. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119551 · Cited by 51
Self-citationTan, Y., Liu, Y., Liu, Y., Ma, R., Luo, J., Hong, H., Chen, X., Wang, S., Liu, C., Zhang, Y., et al. (2021) · Research · doi:10.34133/2021/9812523 · Cited by 56
Direct nose to the brain nanomedicine delivery presents a formidable challenge
Yokel, R. A. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1767 · Cited by 65
Correia, A. C., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2274902 · Cited by 62
Wang, T., Qi, J., Ding, N., Dong, X., Zhao, W., Lü, Y., Wang, C., & Wu, W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.020 · Cited by 49
Self-citationEffect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles
Yu, Z., Fan, W., Wang, L., Qi, J., Lü, Y., & Wu, W. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00861 · Cited by 49
Self-citationBahadur, S., Sachan, N., Harwansh, R. K., & Deshmukh, R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200311131658 · Cited by 51
Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery
Nguyen, T., & Duong, V. (2025) · Pharmaceuticals · doi:10.3390/ph18050615 · Cited by 74
Li, Y., Wu, H., Jiang, X., Dong, Y.-F., Zheng, J., & Gao, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.04.001 · Cited by 51
Lin, Y., Hu, C., Chen, A., Feng, X., Liang, H., Yin, S., Zhang, G., & Shao, L. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02701-w · Cited by 49
Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer’s Disease Therapy
Vasileva, L. A., Gaynanova, G. A., Valeeva, F. G., Belyaev, G. P., Zueva, I. V., Bushmeleva, K., Sibgatullina, G., Samigullin, D., Vyshtakalyuk, A. B., Petrov, K. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310494 · Cited by 51
Chan, H. W., Chow, S., Zhang, X., Kwok, P. C. L., & Chow, S. F. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.07.002 · Cited by 48
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
Jin, Z., Han, Y., Zhang, D., Li, Z., Jing, Y., Hu, B., & Sun, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102070 · Cited by 48
Wang, Q., Wong, C., Chan, H. Y. E., Lee, T. W.-Y., & Zuo, Z. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.032 · Cited by 45
Xue, F., Li, X., Qin, L., Liu, X., Li, C., & Adhikari, B. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113886 · Cited by 48
The intragastrointestinal fate of paclitaxel-loaded micelles: Implications on oral drug delivery
Zoya, I., He, H., Wang, L., Qi, J., Lü, Y., & Wu, W. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.09.038 · Cited by 41
Self-citationUppuluri, C. T., Ravi, P. R., & Dalvi, A. V. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108832 · Cited by 43
Liu, D., Wan, B., Qi, J., Dong, X., Zhao, W., Wu, W., Dai, Y., Lü, Y., & Chen, Z. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.11.015 · Cited by 37
Self-citationNose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
Sarma, A., & Das, M. K. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00019-8 · Cited by 42
Moradi, F., & Dashti, N. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02196-x · Cited by 40
In vivo dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging
Yang, Y., Lv, Y., Shen, C., Shi, T., He, H., Qi, J., Dong, X., Zhao, W., Lü, Y., & Wu, W. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.002 · Cited by 34
Self-citationNerli, G., Robla, S., Bartalesi, M., Luceri, C., D’Ambrosio, M., Csaba, N., & Maestrelli, F. (2023) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2023.100332 · Cited by 44
Lee, D., Shen, A. M., Garbuzenko, O. B., & Minko, T. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00967-x · Cited by 40
Badran, M. M., Alanazi, A. E., Ibrahim, M. A., Alshora, D. H., Taha, E. I., & Alomrani, A. H. (2023) · Polymers · doi:10.3390/polym15193890 · Cited by 33
Yang, W., Shi, Y., Zhang, Y., Yang, Y., Du, Y., Yang, Z., Wang, X., Lei, T., Xu, Y., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c09449 · Cited by 36
Alexander, A., Agrawal, M., Chougule, M. B., Saraf, S., & Saraf, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817778-5.00009-9 · Cited by 37
George, M. Y., El-Derany, M. O., Ahmed, Y. M., Zaher, M., Ibrahim, C., Waleed, H., Khaled, H., Khaled, G., Saleh, A., Alshafei, H., et al. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2153831 · Cited by 34
Correia, A. C., Costa, I., Silva, R., Sampaio, P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124631 · Cited by 31
Intranasal delivery of imaging agents to the brain
Almahmoud, A., Parekh, H. S., Paterson, B. M., Tupally, K. R., & Vegh, V. (2024) · Theranostics · doi:10.7150/thno.98473 · Cited by 39
Nanoparticle systems for nose-to-brain delivery
Liu, Q., & Zhang, Q. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00010-x · Cited by 35
Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy
Liu, Y., Xia, X., Zheng, M., & Shi, B. (2024) · Advanced Materials · doi:10.1002/adma.202314354 · Cited by 40
Clementino, A., Marchi, C., Pozzoli, M., Bernini, F., Zimetti, F., & Sonvico, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716380 · Cited by 33
Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles
Butola, M., & Nainwal, N. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02946-z · Cited by 38
Yu, Z., Fan, W., Wang, L., He, H., Lv, Y., Qi, J., Lü, Y., & Wu, W. (2019) · Biomaterials Science · doi:10.1039/c9bm00873j · Cited by 29
Self-citationShah, B. M., Khunt, D., & Misra, M. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00156-5 · Cited by 32
Burilova, E. A., Pashirova, T. N., Zueva, I. V., Гибадуллина, Э. М., Lushchekina, S. V., Sapunova, А. S., Kayumova, R. M., Rogov, A. M., Evtugyn, V. G., Sudakov, I. A., et al. (2020) · Nanoscale · doi:10.1039/d0nr04037a · Cited by 29
Shen, X., Cui, Z., Wei, Y., Huo, Y., Yu, D., Zhang, X., & Mao, S. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100778 · Cited by 33
Ji, X., Cai, Y., Dong, X., Wu, W., & Zhao, W. (2023) · Nanoscale · doi:10.1039/d3nr01018j · Cited by 26
Self-citationIntranasal administration nanosystems for brain-targeted drug delivery
Jiang, Y., Pan, X., Yu, T., & Wang, H. (2023) · Nano Research · doi:10.1007/s12274-023-6026-y · Cited by 32
Bonferoni, M. C., Ferraro, L., Pavan, B., Beggiato, S., Cavalieri, E., Giunchedi, P., & Dalpiaz, A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030106 · Cited by 25
Metadata
- Authors
- Ahmad, E., Feng, Y., Qi, J., Fan, W., Ma, Y., He, H., Xia, F., Dong, X., Zhao, W., Lu, Y., & Wu, W.
- Affiliations
- Fudan University (CN)
- Dahua Hospital (CN)
- Henan University (CN)
- Corresponding author
- Wu, Wei
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 9
- Issue
- 3
- Pages
- 1174-1183
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W2566085093
- Cited by
- 194
- References
- 36
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 23 · 2023: 25 · 2022: 27 · 2021: 23 · 2020: 27 · 2019: 17 · 2018: 16 · 2017: 4
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nanoscale (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (21372063, 81573363)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- nose-to-brain delivery, nanoemulsions, intranasal drug delivery, olfactory bulb, trigeminal nerve, chitosan-coated nanoparticles, particle size effects, mucociliary clearance, fluorescent probes, DiR, coumarin 6, nanoparticle translocation, brain penetration
- MeSH terms
- Administration, Intranasal, Animals, Brain, Nasal Mucosa, Drug Delivery Systems, Rats, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.